Die einde van aktiewe behandeling beteken nie die einde van sorg vir pasiënte met lewerkanker nie. Opvolgsorg sluit in dat u die fisiese toestand van die lewerkankerpasiënt gereeld moet kontroleer om te verseker dat die kanker nie weer voorkom nie.
Die tradisionele simptome van lewerkanker, soos 'n geswelde buik of 'n vergrote lewer, het baie subtiele tekens wat maklik gemis kan word. Moet nooit hierdie tekens ignoreer nie, want vroeë opsporing kan betyds behandel word. "Reader's Dige ..
19 Augustus 2018: Singapoer-biotegnologiemaatskappy Lion TCR Pte. Bpk. is deur die Singapore Health Sciences Authority (HSA) goedgekeur, en sy kandidaatproduk (LioCyx ™) kan gebruik word vir fase I / II kliniese navorsing vir die behandeling.
Hepatitis C is primarily to blame for liver cancer, one of the deadliest cancers. In addition, complications of fatty liver disease are also a cause of liver cancer. At present, researchers are trying to treat liver cancer by imp..
Research reports published in the Journal of Cancer Epidemiology, Biomarkers, and Prevention show that there is a negative correlation between circulating 25-hydroxyvitamin D [25 (OH) D] levels and liver cancer risk and chron..
'n Navorsingspan by die Kankernavorsingsinstituut (CSI) van die Nasionale Universiteit van Singapoer het 'n nuwe peptiedmiddel genaamd FFW ontwikkel wat die ontwikkeling van hepatosellulêre karsinoom (HCC) of primêre lewer van ongeveer.
The Swiss Roche Group announced yesterday that TECENTRIQ® (atezolizumab) in combination with Avastin® (bevacizumab) has been approved by the US Food and Drug Administration (FDA) for breakthrough therapy for initial (first-line)..
According to a study published in the New England Journal of Medicine published on July 5, Cabozantinib's overall and progression-free survival in patients with advanced hepatocellular carcinoma was significantly better than the p..
Liver cancerLiver cancer is a typical vascular-rich tumor, and tumor blood vessels play a very important role in the development of liver cancer. Therefore, the current targeted therapy of liver cancer is carried out around anti-a..
Dova Pharmaceuticals said that the US Food and Drug Administration (FDA) approved its subsidiary AkaRx's new drug Doptelet (avatrombopag) tablets for treating low platelet counts (thrombocytopenia) in adults with chronic liver dis..